Baldassarre Stea Selected Research

Baldassarre Stea Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 02/2004
10	Brain Neoplasms (Brain Tumor) 01/2022 - 06/2003
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2006
5	Breast Neoplasms (Breast Cancer) 11/2009 - 09/2002
4	Melanoma (Melanoma, Malignant) 12/2017 - 01/2010
4	Glioblastoma (Glioblastoma Multiforme) 12/2009 - 12/2003
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 10/2018
3	Skin Neoplasms (Skin Cancer) 12/2017 - 10/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2013 - 09/2005
3	Hypoxia (Hypoxemia) 10/2012 - 09/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 05/2019
2	Fatigue 01/2020 - 09/2005
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 10/2018
2	Disease Progression 10/2019 - 01/2017
2	Glioma (Gliomas) 08/2016 - 04/2006
1	Hyperthermia 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Leukemia 10/2018
1	Scleredema Adultorum 01/2016
1	Uveal melanoma 09/2015
1	Exanthema (Rash) 03/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2012
1	Orbital lymphoma 01/2009
1	Cataract (Cataracts) 01/2009
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2008
1	Lymphoma (Lymphomas) 05/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2008
1	Radiation Pneumonitis 09/2005
1	Retinoblastoma (Glioblastoma, Retinal) 02/2004
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2004
1	Squamous Cell Carcinoma of Head and Neck 02/2004
1	Carcinogenesis 02/2004
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2003
1	Radiodermatitis 01/2002

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 10/2012 - 09/2002
5	efaproxiral (RSR-13)IBA 12/2007 - 06/2003
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 05/2008
3	Hemoglobins (Hemoglobin)IBA 12/2007 - 01/2006
2	Bendamustine Hydrochloride FDA Link 01/2020 - 10/2018
2	ErbB Receptors (EGF Receptor)IBA 10/2012 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 11/2009 - 07/2009
2	EnzymesIBA 07/2009 - 07/2006
2	iotrexIBA 07/2008 - 04/2006
2	Oxygen (Dioxygen)IBA 03/2006 - 01/2006
1	Busulfan (Busulfex)FDA Link 01/2020
1	fludarabineIBA 01/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	Melphalan (Alkeran)FDA LinkGeneric 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	pembrolizumabIBA 10/2019
1	IpilimumabIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 08/2016
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 08/2016
1	Iodine-125IBA 09/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2013
1	Biomarkers (Surrogate Marker)IBA 10/2012
1	Proto-Oncogene Proteins c-metIBA 12/2009
1	amuvatinibIBA 12/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2009
1	DNA (Deoxyribonucleic Acid)IBA 07/2009
1	Rad51 RecombinaseIBA 07/2009
1	Rituximab (Mabthera)FDA Link 05/2008
1	Vincristine (Oncovin)FDA LinkGeneric 05/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2008
1	Prednisone (Sone)FDA LinkGeneric 05/2008
1	ErbB-2 ReceptorIBA 07/2006
1	Hormones (Hormone)IBA 07/2006
1	Radiation-Sensitizing AgentsIBA 01/2006
1	Histidine (L-Histidine)FDA Link 02/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2004
1	Tyrosine Kinase InhibitorsIBA 12/2003
1	Gefitinib (Iressa)FDA Link 12/2003
1	ParaffinIBA 09/2002
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 09/2002
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2002
1	Formaldehyde (Formol)FDA Link 09/2002
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2002

Therapy/Procedure

26	Radiotherapy 01/2022 - 01/2003
7	Brachytherapy 12/2017 - 04/2006
5	Therapeutics 01/2022 - 12/2009
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 10/2018
3	Drug Therapy (Chemotherapy) 12/2017 - 01/2010
2	Transplantation 01/2022 - 01/2020
2	Immunotherapy 01/2022 - 01/2017
2	Catheters 07/2008 - 04/2006
1	Cryosurgery 01/2022
1	Radiofrequency Ablation 01/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Hematopoietic Stem Cell Transplantation 05/2019
1	Cell Transplantation 05/2019
1	Drug Tapering 03/2013
1	Adjuvant Chemotherapy 01/2010
1	Lenses 01/2009
1	Re-Irradiation 04/2006
1	Induction Chemotherapy 09/2005